NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $152 million versus the consensus estimate of $141.65 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.